A comprehensive view of Phase 3 Trial. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca reports positive high-level results from Phase 3 study of eplontersen to treat hereditary transthyretin-mediated amyloid polyneuropathy; ATTRv-PN is a rare, progressive disease that leads to peripheral nerve damage with motor disability

Pfizer and Astellas report Phase 3 study shows Xtandi enzalutamide plus leuprolide significantly improves metastasis-free survival in men with non-metastatic prostate cancer

GSK announces positive results from phase III trial of 5-in-1 meningococcal ABCWY vaccine candidate

Weekly antibody treatment with dupilumab improved chronic food allergy symptoms in young adults with eosinophilic esophagitis; about 30% to 40% of patients do not respond to current treatments that include food elimination diets, proton-pump inhibitors

AstraZeneca reports trial results showing Imfinzi improves lung cancer survival; drug given in combination with neoadjuvant chemotherapy before surgery and as adjuvant monotherapy after surgery

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count